Details
CSL Limited is a global biotechnology company that develops and delivers life saving therapies for people with serious and rare diseases. Headquartered in Australia, the company operates internationally through its businesses in plasma therapies, vaccines, and specialty medicines.
CSL is best known for its plasma derived therapies, which are used to treat conditions such as immune deficiencies, bleeding disorders, and neurological diseases. The company also operates CSL Seqirus, one of the world’s leading influenza vaccine providers, and CSL Behring, which focuses on rare and serious medical conditions.
The company is driven by a strong commitment to innovation, scientific research, and patient outcomes. CSL invests heavily in biotechnology, clinical development, and manufacturing to ensure the availability of high quality medical treatments worldwide.
Employees work in a highly scientific and regulated environment across research, development, manufacturing, quality assurance, and commercial roles. The culture emphasizes integrity, collaboration, and a shared mission to save and improve lives globally.